StrataRisk™ leverages AI-driven algorithms to provide precise risk assessments for common diseases, including cardiovascular and metabolic disorders, as well as cancer susceptibility.
▪️ Swing by our booth at ACMG to learn more: #233 ▪️ #PrecisionMedicine #ACMGMtg25 #PRS

Galatea Bio Launches StrataRisk™ Polygenic Risk Score to Scale Common Disease Risk Assessment and Reporting at the 2025 ACMG Conference MIAMI LAKES, Fla., March 18, 2025 (GLOBE NEWSWIRE) -- Galatea Bio, a leader in precision health, announced today the launch of StrataRisk™, a Polygenic...

We're excited to announce our launch of StrataRisk™, a cutting-edge Polygenic Risk Score (PRS) SaaS platform, at the ACMG - American College of Medical Genetics and Genomics 's 2025 Annual Conference.
🗞️ Press Release: bit.ly/4hkhAcH